| UniProt ID | RERE_HUMAN | |
|---|---|---|
| UniProt AC | Q9P2R6 | |
| Protein Name | Arginine-glutamic acid dipeptide repeats protein | |
| Gene Name | RERE | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 1566 | |
| Subcellular Localization | Nucleus . Localized in nuclear bodies of variables size. Colocalized with PML and BAX in nuclear PODs. | |
| Protein Description | Plays a role as a transcriptional repressor during development. May play a role in the control of cell survival. Overexpression of RERE recruits BAX to the nucleus particularly to POD and triggers caspase-3 activation, leading to cell death.. | |
| Protein Sequence | MTADKDKDKDKEKDRDRDRDREREKRDKARESENSRPRRSCTLEGGAKNYAESDHSEDEDNDNNSATAEESTKKNKKKPPKKKSRYERTDTGEITSYITEDDVVYRPGDCVYIESRRPNTPYFICSIQDFKLVHNSQACCRSPTPALCDPPACSLPVASQPPQHLSEAGRGPVGSKRDHLLMNVKWYYRQSEVPDSVYQHLVQDRHNENDSGRELVITDPVIKNRELFISDYVDTYHAAALRGKCNISHFSDIFAAREFKARVDSFFYILGYNPETRRLNSTQGEIRVGPSHQAKLPDLQPFPSPDGDTVTQHEELVWMPGVNDCDLLMYLRAARSMAAFAGMCDGGSTEDGCVAASRDDTTLNALNTLHESGYDAGKALQRLVKKPVPKLIEKCWTEDEVKRFVKGLRQYGKNFFRIRKELLPNKETGELITFYYYWKKTPEAASSRAHRRHRRQAVFRRIKTRTASTPVNTPSRPPSSEFLDLSSASEDDFDSEDSEQELKGYACRHCFTTTSKDWHHGGRENILLCTDCRIHFKKYGELPPIEKPVDPPPFMFKPVKEEDDGLSGKHSMRTRRSRGSMSTLRSGRKKQPASPDGRTSPINEDIRSSGRNSPSAASTSSNDSKAETVKKSAKKVKEEASSPLKSNKRQREKVASDTEEADRTSSKKTKTQEISRPNSPSEGEGESSDSRSVNDEGSSDPKDIDQDNRSTSPSIPSPQDNESDSDSSAQQQMLQAQPPALQAPTGVTPAPSSAPPGTPQLPTPGPTPSATAVPPQGSPTASQAPNQPQAPTAPVPHTHIQQAPALHPQRPPSPHPPPHPSPHPPLQPLTGSAGQPSAPSHAQPPLHGQGPPGPHSLQAGPLLQHPGPPQPFGLPPQASQGQAPLGTSPAAAYPHTSLQLPASQSALQSQQPPREQPLPPAPLAMPHIKPPPTTPIPQLPAPQAHKHPPHLSGPSPFSMNANLPPPPALKPLSSLSTHHPPSAHPPPLQLMPQSQPLPSSPAQPPGLTQSQNLPPPPASHPPTGLHQVAPQPPFAQHPFVPGGPPPITPPTCPSTSTPPAGPGTSAQPPCSGAAASGGSIAGGSSCPLPTVQIKEEALDDAEEPESPPPPPRSPSPEPTVVDTPSHASQSARFYKHLDRGYNSCARTDLYFMPLAGSKLAKKREEAIEKAKREAEQKAREEREREKEKEKEREREREREREAERAAKASSSAHEGRLSDPQLSGPGHMRPSFEPPPTTIAAVPPYIGPDTPALRTLSEYARPHVMSPTNRNHPFYMPLNPTDPLLAYHMPGLYNVDPTIRERELREREIREREIRERELRERMKPGFEVKPPELDPLHPAANPMEHFARHSALTIPPTAGPHPFASFHPGLNPLERERLALAGPQLRPEMSYPDRLAAERIHAERMASLTSDPLARLQMFNVTPHHHQHSHIHSHLHLHQQDPLHQGSAGPVHPLVDPLTAGPHLARFPYPPGTLPNPLLGQPPHEHEMLRHPVFGTPYPRDLPGAIPPPMSAAHQLQAMHAQSAELQRLAMEQQWLHGHPHMHGGHLPSQEDYYSRLKKEGDKQL | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 5 | 2-Hydroxyisobutyrylation | ---MTADKDKDKDKE ---CCCCCCCHHHHH | 65.30 | - | |
| 35 | Phosphorylation | KARESENSRPRRSCT HHHHCHHCCCCCCEE | 39.34 | 29214152 | |
| 36 | Ubiquitination | ARESENSRPRRSCTL HHHCHHCCCCCCEEC | 40.08 | 33845483 | |
| 40 | Phosphorylation | ENSRPRRSCTLEGGA HHCCCCCCEECCCCH | 16.84 | 33259812 | |
| 40 (in isoform 2) | Phosphorylation | - | 16.84 | - | |
| 42 | Phosphorylation | SRPRRSCTLEGGAKN CCCCCCEECCCCHHC | 29.14 | 29396449 | |
| 45 (in isoform 2) | Phosphorylation | - | 44.46 | - | |
| 46 (in isoform 2) | Phosphorylation | - | 24.81 | - | |
| 50 | Phosphorylation | LEGGAKNYAESDHSE CCCCHHCCCCCCCCC | 15.84 | 23927012 | |
| 53 | Phosphorylation | GAKNYAESDHSEDED CHHCCCCCCCCCCCC | 32.24 | 26503892 | |
| 56 | Phosphorylation | NYAESDHSEDEDNDN CCCCCCCCCCCCCCC | 52.30 | 26503892 | |
| 65 | Phosphorylation | DEDNDNNSATAEEST CCCCCCCCCCHHHHH | 33.00 | 23403867 | |
| 67 | Phosphorylation | DNDNNSATAEESTKK CCCCCCCCHHHHHHH | 34.13 | 23403867 | |
| 71 | Phosphorylation | NSATAEESTKKNKKK CCCCHHHHHHHCCCC | 36.71 | 23403867 | |
| 72 | Phosphorylation | SATAEESTKKNKKKP CCCHHHHHHHCCCCC | 49.68 | 23403867 | |
| 87 (in isoform 2) | Phosphorylation | - | 48.25 | - | |
| 88 (in isoform 2) | Phosphorylation | - | 29.03 | - | |
| 102 | Phosphorylation | TSYITEDDVVYRPGD EEEECCCCEEECCCC | 26.08 | 32645325 | |
| 102 (in isoform 2) | Phosphorylation | - | 26.08 | - | |
| 110 | Ubiquitination | VVYRPGDCVYIESRR EEECCCCEEEEECCC | 2.87 | 21890473 | |
| 110 (in isoform 2) | Ubiquitination | - | 2.87 | 21890473 | |
| 120 | Phosphorylation | IESRRPNTPYFICSI EECCCCCCCEEEEEE | 23.27 | 25159151 | |
| 122 | Phosphorylation | SRRPNTPYFICSIQD CCCCCCCEEEEEECC | 11.97 | 28450419 | |
| 125 (in isoform 2) | Phosphorylation | - | 1.78 | - | |
| 126 | Phosphorylation | NTPYFICSIQDFKLV CCCEEEEEECCEEEE | 20.61 | 23186163 | |
| 136 | Phosphorylation | DFKLVHNSQACCRSP CEEEECCCCCCCCCC | 12.32 | 23401153 | |
| 142 | Phosphorylation | NSQACCRSPTPALCD CCCCCCCCCCCCCCC | 21.15 | 23401153 | |
| 144 | Phosphorylation | QACCRSPTPALCDPP CCCCCCCCCCCCCCC | 23.57 | 30266825 | |
| 154 | Phosphorylation | LCDPPACSLPVASQP CCCCCCCCCCCCCCC | 37.50 | 23663014 | |
| 159 | Phosphorylation | ACSLPVASQPPQHLS CCCCCCCCCCCHHHH | 43.38 | 30266825 | |
| 166 | Phosphorylation | SQPPQHLSEAGRGPV CCCCHHHHHCCCCCC | 24.23 | 20873877 | |
| 191 | Phosphorylation | VKWYYRQSEVPDSVY EEEEECHHCCCHHHH | 31.40 | 27732954 | |
| 196 | Phosphorylation | RQSEVPDSVYQHLVQ CHHCCCHHHHHHHHH | 19.36 | 27732954 | |
| 198 | Phosphorylation | SEVPDSVYQHLVQDR HCCCHHHHHHHHHCC | 8.31 | 27732954 | |
| 223 | Ubiquitination | VITDPVIKNRELFIS EEECCEECCCEEEHH | 50.62 | 29967540 | |
| 265 | Phosphorylation | EFKARVDSFFYILGY HHHHHHHHEEHHHCC | 17.88 | 25278378 | |
| 268 | Phosphorylation | ARVDSFFYILGYNPE HHHHHEEHHHCCCHH | 8.01 | 25278378 | |
| 272 | Phosphorylation | SFFYILGYNPETRRL HEEHHHCCCHHHCCC | 24.89 | 25278378 | |
| 276 | Phosphorylation | ILGYNPETRRLNSTQ HHCCCHHHCCCCCCC | 23.50 | 25278378 | |
| 281 | Phosphorylation | PETRRLNSTQGEIRV HHHCCCCCCCCEEEE | 27.05 | - | |
| 282 | Phosphorylation | ETRRLNSTQGEIRVG HHCCCCCCCCEEEEC | 39.25 | - | |
| 304 | Phosphorylation | PDLQPFPSPDGDTVT CCCCCCCCCCCCCCC | 35.68 | 26074081 | |
| 309 | Phosphorylation | FPSPDGDTVTQHEEL CCCCCCCCCCCCCEE | 30.86 | 26074081 | |
| 311 | Phosphorylation | SPDGDTVTQHEELVW CCCCCCCCCCCEEEE | 26.71 | 26074081 | |
| 336 | Phosphorylation | MYLRAARSMAAFAGM HHHHHHHHHHHHHCC | 14.19 | - | |
| 336 | Ubiquitination | MYLRAARSMAAFAGM HHHHHHHHHHHHHCC | 14.19 | 21890473 | |
| 348 | Phosphorylation | AGMCDGGSTEDGCVA HCCCCCCCCCCCCEE | 33.87 | - | |
| 349 | Phosphorylation | GMCDGGSTEDGCVAA CCCCCCCCCCCCEEE | 41.17 | - | |
| 357 | Phosphorylation | EDGCVAASRDDTTLN CCCCEEECCCCCHHH | 26.89 | - | |
| 378 | Ubiquitination | ESGYDAGKALQRLVK HHCCCHHHHHHHHHH | 47.87 | 22817900 | |
| 378 (in isoform 1) | Ubiquitination | - | 47.87 | 21890473 | |
| 394 | Ubiquitination | PVPKLIEKCWTEDEV CHHHHHHHHCCHHHH | 28.25 | 29967540 | |
| 441 | Phosphorylation | FYYYWKKTPEAASSR EEEEHHHCHHHHHHH | 23.72 | 25072903 | |
| 466 | Phosphorylation | FRRIKTRTASTPVNT HHHHHCCCCCCCCCC | 30.14 | 22817900 | |
| 468 | Phosphorylation | RIKTRTASTPVNTPS HHHCCCCCCCCCCCC | 32.41 | 22817900 | |
| 473 | Phosphorylation | TASTPVNTPSRPPSS CCCCCCCCCCCCCCH | 23.91 | 22817900 | |
| 475 | Phosphorylation | STPVNTPSRPPSSEF CCCCCCCCCCCCHHH | 56.21 | 17081983 | |
| 479 | Phosphorylation | NTPSRPPSSEFLDLS CCCCCCCCHHHCCCC | 45.22 | - | |
| 486 | Phosphorylation | SSEFLDLSSASEDDF CHHHCCCCCCCCCCC | 24.43 | 23909892 | |
| 487 | Phosphorylation | SEFLDLSSASEDDFD HHHCCCCCCCCCCCC | 43.01 | 23909892 | |
| 489 | Phosphorylation | FLDLSSASEDDFDSE HCCCCCCCCCCCCCC | 43.43 | 23909892 | |
| 495 | Phosphorylation | ASEDDFDSEDSEQEL CCCCCCCCCCHHHHH | 43.21 | 23909892 | |
| 498 | Phosphorylation | DDFDSEDSEQELKGY CCCCCCCHHHHHHHE | 36.81 | 23909892 | |
| 552 (in isoform 2) | Phosphorylation | - | 30.23 | - | |
| 559 (in isoform 2) | Phosphorylation | - | 14.54 | - | |
| 560 | Sumoylation | PFMFKPVKEEDDGLS CCCCCCCCCCCCCCC | 65.01 | 28112733 | |
| 561 (in isoform 2) | Phosphorylation | - | 67.88 | - | |
| 565 (in isoform 2) | Phosphorylation | - | 33.78 | - | |
| 577 | O-linked_Glycosylation | HSMRTRRSRGSMSTL CHHHCCCCCCCHHHH | 37.39 | 30379171 | |
| 577 | Phosphorylation | HSMRTRRSRGSMSTL CHHHCCCCCCCHHHH | 37.39 | 20873877 | |
| 578 | Methylation | SMRTRRSRGSMSTLR HHHCCCCCCCHHHHH | 39.12 | 115491123 | |
| 580 | Phosphorylation | RTRRSRGSMSTLRSG HCCCCCCCHHHHHCC | 14.40 | 23401153 | |
| 581 | Ubiquitination | TRRSRGSMSTLRSGR CCCCCCCHHHHHCCC | 3.85 | 21890473 | |
| 582 | Phosphorylation | RRSRGSMSTLRSGRK CCCCCCHHHHHCCCC | 26.45 | 20873877 | |
| 583 | Phosphorylation | RSRGSMSTLRSGRKK CCCCCHHHHHCCCCC | 19.97 | 26434776 | |
| 590 | Ubiquitination | TLRSGRKKQPASPDG HHHCCCCCCCCCCCC | 61.22 | 33845483 | |
| 594 | Phosphorylation | GRKKQPASPDGRTSP CCCCCCCCCCCCCCC | 30.15 | 20201521 | |
| 599 | Phosphorylation | PASPDGRTSPINEDI CCCCCCCCCCCCHHH | 44.37 | 29255136 | |
| 600 | Phosphorylation | ASPDGRTSPINEDIR CCCCCCCCCCCHHHH | 23.56 | 29255136 | |
| 608 | Phosphorylation | PINEDIRSSGRNSPS CCCHHHHHCCCCCCC | 37.16 | 23401153 | |
| 609 | Phosphorylation | INEDIRSSGRNSPSA CCHHHHHCCCCCCCC | 31.74 | 23927012 | |
| 613 | Phosphorylation | IRSSGRNSPSAASTS HHHCCCCCCCCCCCC | 20.90 | 29255136 | |
| 615 | Phosphorylation | SSGRNSPSAASTSSN HCCCCCCCCCCCCCC | 35.97 | 25159151 | |
| 618 | Phosphorylation | RNSPSAASTSSNDSK CCCCCCCCCCCCHHH | 28.65 | 23927012 | |
| 619 | Phosphorylation | NSPSAASTSSNDSKA CCCCCCCCCCCHHHH | 31.29 | 23927012 | |
| 620 | Phosphorylation | SPSAASTSSNDSKAE CCCCCCCCCCHHHHH | 25.34 | 23927012 | |
| 621 | Phosphorylation | PSAASTSSNDSKAET CCCCCCCCCHHHHHH | 44.75 | 23927012 | |
| 624 | Phosphorylation | ASTSSNDSKAETVKK CCCCCCHHHHHHHHH | 37.71 | 23927012 | |
| 635 | Acetylation | TVKKSAKKVKEEASS HHHHHHHHHHHHHCC | 59.25 | 7707267 | |
| 637 | Sumoylation | KKSAKKVKEEASSPL HHHHHHHHHHHCCCC | 59.73 | - | |
| 637 | Sumoylation | KKSAKKVKEEASSPL HHHHHHHHHHHCCCC | 59.73 | 28112733 | |
| 641 | Phosphorylation | KKVKEEASSPLKSNK HHHHHHHCCCCCCCH | 35.45 | 30266825 | |
| 642 | Phosphorylation | KVKEEASSPLKSNKR HHHHHHCCCCCCCHH | 41.10 | 29255136 | |
| 645 | Acetylation | EEASSPLKSNKRQRE HHHCCCCCCCHHHHH | 56.20 | 7707279 | |
| 646 | Phosphorylation | EASSPLKSNKRQREK HHCCCCCCCHHHHHH | 56.09 | 23312004 | |
| 656 | Phosphorylation | RQREKVASDTEEADR HHHHHHCCCCHHHHH | 48.31 | 29255136 | |
| 658 | Phosphorylation | REKVASDTEEADRTS HHHHCCCCHHHHHHC | 32.98 | 30278072 | |
| 664 | Phosphorylation | DTEEADRTSSKKTKT CCHHHHHHCCCCCCC | 37.59 | 23403867 | |
| 665 | Phosphorylation | TEEADRTSSKKTKTQ CHHHHHHCCCCCCCE | 40.84 | 23403867 | |
| 666 | Phosphorylation | EEADRTSSKKTKTQE HHHHHHCCCCCCCEE | 37.24 | 23403867 | |
| 671 | Phosphorylation | TSSKKTKTQEISRPN HCCCCCCCEECCCCC | 36.34 | 29255136 | |
| 675 | Phosphorylation | KTKTQEISRPNSPSE CCCCEECCCCCCCCC | 40.72 | 29255136 | |
| 679 | Phosphorylation | QEISRPNSPSEGEGE EECCCCCCCCCCCCC | 32.27 | 29255136 | |
| 681 | Phosphorylation | ISRPNSPSEGEGESS CCCCCCCCCCCCCCC | 59.04 | 30266825 | |
| 687 | Phosphorylation | PSEGEGESSDSRSVN CCCCCCCCCCCCCCC | 50.75 | 30266825 | |
| 688 | Phosphorylation | SEGEGESSDSRSVND CCCCCCCCCCCCCCC | 34.99 | 30266825 | |
| 690 | Phosphorylation | GEGESSDSRSVNDEG CCCCCCCCCCCCCCC | 28.53 | 30266825 | |
| 692 | Phosphorylation | GESSDSRSVNDEGSS CCCCCCCCCCCCCCC | 29.26 | 25849741 | |
| 698 | Phosphorylation | RSVNDEGSSDPKDID CCCCCCCCCCHHHCC | 29.53 | 28348404 | |
| 699 | Phosphorylation | SVNDEGSSDPKDIDQ CCCCCCCCCHHHCCC | 69.64 | 23532336 | |
| 770 | Ubiquitination | TPGPTPSATAVPPQG CCCCCCCCCCCCCCC | 10.77 | 23000965 | |
| 776 | Ubiquitination | SATAVPPQGSPTASQ CCCCCCCCCCCCHHH | 59.95 | 23000965 | |
| 867 | Ubiquitination | GPLLQHPGPPQPFGL CCCCCCCCCCCCCCC | 44.38 | 21890473 | |
| 867 (in isoform 2) | Ubiquitination | - | 44.38 | 21890473 | |
| 933 | Phosphorylation | PHIKPPPTTPIPQLP CCCCCCCCCCCCCCC | 51.48 | 27251275 | |
| 934 | Phosphorylation | HIKPPPTTPIPQLPA CCCCCCCCCCCCCCC | 25.62 | 27251275 | |
| 955 | Phosphorylation | PPHLSGPSPFSMNAN CCCCCCCCCCCCCCC | 41.94 | 25159151 | |
| 1056 | Ubiquitination | PPTCPSTSTPPAGPG CCCCCCCCCCCCCCC | 43.16 | 21890473 | |
| 1056 (in isoform 2) | Ubiquitination | - | 43.16 | 21890473 | |
| 1062 | Ubiquitination | TSTPPAGPGTSAQPP CCCCCCCCCCCCCCC | 45.02 | 23000965 | |
| 1093 | Ubiquitination | CPLPTVQIKEEALDD CCCCCEEEEHHHHCC | 5.43 | 21890473 | |
| 1106 | Phosphorylation | DDAEEPESPPPPPRS CCCCCCCCCCCCCCC | 54.12 | 30266825 | |
| 1113 | Phosphorylation | SPPPPPRSPSPEPTV CCCCCCCCCCCCCEE | 35.19 | 30266825 | |
| 1115 | Phosphorylation | PPPPRSPSPEPTVVD CCCCCCCCCCCEEEC | 43.04 | 30266825 | |
| 1119 | Phosphorylation | RSPSPEPTVVDTPSH CCCCCCCEEECCCCC | 31.34 | 30266825 | |
| 1123 | Phosphorylation | PEPTVVDTPSHASQS CCCEEECCCCCHHHH | 18.32 | 30266825 | |
| 1125 | Phosphorylation | PTVVDTPSHASQSAR CEEECCCCCHHHHHH | 33.50 | 23663014 | |
| 1128 | Phosphorylation | VDTPSHASQSARFYK ECCCCCHHHHHHHHH | 21.17 | 23663014 | |
| 1130 | Phosphorylation | TPSHASQSARFYKHL CCCCHHHHHHHHHHH | 20.93 | 23663014 | |
| 1134 | Phosphorylation | ASQSARFYKHLDRGY HHHHHHHHHHHHCCC | 7.61 | 22468782 | |
| 1135 | Ubiquitination | SQSARFYKHLDRGYN HHHHHHHHHHHCCCC | 34.67 | 21890473 | |
| 1135 (in isoform 1) | Ubiquitination | - | 34.67 | 21890473 | |
| 1150 | Phosphorylation | SCARTDLYFMPLAGS CCCCCCEEECCCCCH | 10.71 | 17360941 | |
| 1157 | Phosphorylation | YFMPLAGSKLAKKRE EECCCCCHHHHHHHH | 20.91 | - | |
| 1158 | Acetylation | FMPLAGSKLAKKREE ECCCCCHHHHHHHHH | 52.09 | 25953088 | |
| 1231 | O-linked_Glycosylation | GPGHMRPSFEPPPTT CCCCCCCCCCCCCCE | 31.70 | 30379171 | |
| 1237 | O-linked_Glycosylation | PSFEPPPTTIAAVPP CCCCCCCCEEECCCC | 36.29 | 30379171 | |
| 1238 | O-linked_Glycosylation | SFEPPPTTIAAVPPY CCCCCCCEEECCCCC | 17.88 | 30379171 | |
| 1238 | Phosphorylation | SFEPPPTTIAAVPPY CCCCCCCEEECCCCC | 17.88 | 24719451 | |
| 1250 | Phosphorylation | PPYIGPDTPALRTLS CCCCCCCCHHHHHHH | 17.37 | 24719451 | |
| 1255 | Phosphorylation | PDTPALRTLSEYARP CCCHHHHHHHHHCCC | 35.17 | 23403867 | |
| 1257 | Phosphorylation | TPALRTLSEYARPHV CHHHHHHHHHCCCCC | 28.13 | 23403867 | |
| 1259 | Phosphorylation | ALRTLSEYARPHVMS HHHHHHHHCCCCCCC | 12.44 | 23403867 | |
| 1266 | Phosphorylation | YARPHVMSPTNRNHP HCCCCCCCCCCCCCC | 27.73 | 23401153 | |
| 1268 | Phosphorylation | RPHVMSPTNRNHPFY CCCCCCCCCCCCCCC | 39.23 | 23927012 | |
| 1282 | Ubiquitination | YMPLNPTDPLLAYHM CCCCCCCCCHHHHCC | 32.86 | 21890473 | |
| 1287 | Phosphorylation | PTDPLLAYHMPGLYN CCCCHHHHCCCCCCC | 9.91 | - | |
| 1288 | Ubiquitination | TDPLLAYHMPGLYNV CCCHHHHCCCCCCCC | 15.45 | 23000965 | |
| 1324 | Ubiquitination | RELRERMKPGFEVKP HHHHHHCCCCCCCCC | 48.48 | 23000965 | |
| 1324 (in isoform 1) | Ubiquitination | - | 48.48 | 21890473 | |
| 1330 | Ubiquitination | MKPGFEVKPPELDPL CCCCCCCCCCCCCCC | 47.89 | 23000965 | |
| 1387 | Methylation | ALAGPQLRPEMSYPD HHCCCCCCCCCCCCH | 21.64 | 115491099 | |
| 1395 | Methylation | PEMSYPDRLAAERIH CCCCCCHHHHHHHHH | 23.01 | 115491107 | |
| 1400 | Methylation | PDRLAAERIHAERMA CHHHHHHHHHHHHHH | 22.67 | 115491115 | |
| 1405 | Methylation | AERIHAERMASLTSD HHHHHHHHHHHCCCC | 27.10 | 115491083 | |
| 1408 | Phosphorylation | IHAERMASLTSDPLA HHHHHHHHCCCCHHH | 23.88 | 28555341 | |
| 1416 | Methylation | LTSDPLARLQMFNVT CCCCHHHHHHHCCCC | 32.89 | 115491091 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of RERE_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RERE_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RERE_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| ATN1_HUMAN | ATN1 | physical | 10814707 | |
| LZTR1_HUMAN | LZTR1 | physical | 20211142 | |
| ACT1_DROME | Act5C | physical | 16481466 | |
| 7UP1_DROME | svp | physical | 16481466 | |
| 7UP2_DROME | svp | physical | 16481466 | |
| NR2E1_HUMAN | NR2E1 | physical | 16481466 | |
| HDAC1_HUMAN | HDAC1 | physical | 16481466 | |
| HDAC2_HUMAN | HDAC2 | physical | 16481466 | |
| EHMT2_HUMAN | EHMT2 | physical | 18451879 | |
| H32_HUMAN | HIST2H3C | physical | 18451879 | |
| KR412_HUMAN | KRTAP4-12 | physical | 16713569 | |
| PLS1_HUMAN | PLSCR1 | physical | 16713569 | |
| TRI22_HUMAN | TRIM22 | physical | 16713569 | |
| ATN1_HUMAN | ATN1 | physical | 16713569 | |
| MTG8R_HUMAN | CBFA2T2 | physical | 16713569 | |
| FBLN4_HUMAN | EFEMP2 | physical | 16713569 | |
| PKCB1_HUMAN | ZMYND8 | physical | 16713569 | |
| PSA3_HUMAN | PSMA3 | physical | 16713569 | |
| PRC2A_HUMAN | PRRC2A | physical | 16713569 | |
| ALG13_HUMAN | ALG13 | physical | 16713569 | |
| ECM1_HUMAN | ECM1 | physical | 16713569 | |
| FBLN3_HUMAN | EFEMP1 | physical | 16713569 | |
| PRC2B_HUMAN | PRRC2B | physical | 16713569 | |
| KAT6A_HUMAN | KAT6A | physical | 16713569 | |
| RFOX2_HUMAN | RBFOX2 | physical | 16713569 | |
| HDAC1_HUMAN | HDAC1 | physical | 17150957 | |
| EP300_HUMAN | EP300 | physical | 17150957 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-53; SER-56; SER-675 ANDSER-679, AND MASS SPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-53; SER-56 AND SER-642,AND MASS SPECTROMETRY. | |
| "Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-304; SER-1106; SER-1113AND SER-1115, AND MASS SPECTROMETRY. | |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-594 AND THR-599, ANDMASS SPECTROMETRY. | |
| "Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-613 AND SER-656, ANDMASS SPECTROMETRY. | |